1. Home
  2. ATAI vs EVGO Comparison

ATAI vs EVGO Comparison

Compare ATAI & EVGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATAI
  • EVGO
  • Stock Information
  • Founded
  • ATAI 2018
  • EVGO 2010
  • Country
  • ATAI Germany
  • EVGO United States
  • Employees
  • ATAI N/A
  • EVGO N/A
  • Industry
  • ATAI Biotechnology: Pharmaceutical Preparations
  • EVGO Other Specialty Stores
  • Sector
  • ATAI Health Care
  • EVGO Consumer Discretionary
  • Exchange
  • ATAI Nasdaq
  • EVGO Nasdaq
  • Market Cap
  • ATAI 444.7M
  • EVGO 462.9M
  • IPO Year
  • ATAI 2021
  • EVGO N/A
  • Fundamental
  • Price
  • ATAI $3.76
  • EVGO $3.38
  • Analyst Decision
  • ATAI Strong Buy
  • EVGO Buy
  • Analyst Count
  • ATAI 3
  • EVGO 9
  • Target Price
  • ATAI $13.33
  • EVGO $6.13
  • AVG Volume (30 Days)
  • ATAI 6.6M
  • EVGO 3.7M
  • Earning Date
  • ATAI 08-12-2025
  • EVGO 08-05-2025
  • Dividend Yield
  • ATAI N/A
  • EVGO N/A
  • EPS Growth
  • ATAI N/A
  • EVGO N/A
  • EPS
  • ATAI N/A
  • EVGO N/A
  • Revenue
  • ATAI $1,863,000.00
  • EVGO $276,954,000.00
  • Revenue This Year
  • ATAI $423.05
  • EVGO $40.85
  • Revenue Next Year
  • ATAI N/A
  • EVGO $32.70
  • P/E Ratio
  • ATAI N/A
  • EVGO N/A
  • Revenue Growth
  • ATAI 572.56
  • EVGO 45.15
  • 52 Week Low
  • ATAI $1.03
  • EVGO $2.20
  • 52 Week High
  • ATAI $4.00
  • EVGO $9.07
  • Technical
  • Relative Strength Index (RSI)
  • ATAI 69.83
  • EVGO 39.96
  • Support Level
  • ATAI $3.06
  • EVGO $3.82
  • Resistance Level
  • ATAI $3.70
  • EVGO $3.87
  • Average True Range (ATR)
  • ATAI 0.28
  • EVGO 0.21
  • MACD
  • ATAI 0.03
  • EVGO -0.02
  • Stochastic Oscillator
  • ATAI 89.08
  • EVGO 5.75

About ATAI ATAI Life Sciences N.V.

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.

About EVGO EVgo Inc.

EVgo owns and operates a public direct current fast-charging network in the US. Its network of charging stations provides electric vehicle charging infrastructure to consumers and businesses. The network is capable of charging all EV models and meets all charging standards currently available in the US. EVgo partners with national and regional chains of grocery stores, automotive original equipment manufacturers, hotels, shopping centers, gas stations, parking lot operators, local governments, and independent property owners to locate and deploy its EV charging infrastructure.

Share on Social Networks: